BOREF yields 100.00% · MRK yields 2.76%● Live data
📍 BOREF pulled ahead of the other in Year 1
Combined, BOREF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BOREF + MRK for your $10,000?
Borealis Exploration Limited, a technology development company, engages in inventing, patenting, developing, and acquiring new technologies. Its principal technologies include Chorus Meshcon, an electric motor/drive providing high torque at low speeds without compromising high-speed operation and performance; WheelTug, an aircraft electric drive system, which enables ircraft to drive forward and backward without using its engines or external tugs; Avto Metals, a custom-designed material for applications in microelectronic devices, including computers, cell phones, and multifunction digital tools. The company's principal technologies also include Cool Chips, which are devices that use quantum electron thermotunnelling to produce cooling, refrigeration, or air-conditioning, which has applications in cooling electronics, refrigerators and freezers, medical and industrial equipment, buildings, cargo, aircraft, and cars; and Power Chips, a new technology that uses the physical mechanism of thermionics and quantum thermotunnelling to generate electrical power directly from heat, with no moving parts, produce power for laptop computers, buildings, and cars and trucks. It also holds interests in various iron ore deposits. The company was founded in 1965 and is headquartered in Gibraltar, Gibraltar.
Full BOREF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.